Shan Man

9.5k total citations · 1 hit paper
83 papers, 7.5k citations indexed

About

Shan Man is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shan Man has authored 83 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 43 papers in Molecular Biology and 33 papers in Cancer Research. Recurrent topics in Shan Man's work include Angiogenesis and VEGF in Cancer (38 papers), Cancer, Hypoxia, and Metabolism (27 papers) and Cancer Cells and Metastasis (25 papers). Shan Man is often cited by papers focused on Angiogenesis and VEGF in Cancer (38 papers), Cancer, Hypoxia, and Metabolism (27 papers) and Cancer Cells and Metastasis (25 papers). Shan Man collaborates with scholars based in Canada, United States and Italy. Shan Man's co-authors include Robert S. Kerbel, Daniel J. Hicklin, Yuval Shaked, Giulio Francia, Ping Xu, Christina R. Lee, Giannoula Klement, Peter Böhlen, Urban Emmenegger and Janusz Rak and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Shan Man

83 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2000 956 citations Janusz Rak, Shan Man et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shan Man Canada	45	4.1k	3.7k	2.8k	1.2k	772	83	7.5k
Oriol Casanovas Spain	32	3.8k 0.9×	2.3k 0.6×	2.1k 0.8×	896 0.7×	591 0.8×	70	6.2k
Muhammad Al‐Hajj United States	14	5.7k 1.4×	7.9k 2.1×	3.1k 1.1×	895 0.7×	842 1.1×	19	10.6k
Michail Shipitsin United States	15	5.1k 1.2×	5.5k 1.5×	2.8k 1.0×	1.0k 0.8×	612 0.8×	21	8.5k
Livio Trusolino Italy	51	4.9k 1.2×	4.4k 1.2×	2.2k 0.8×	1.7k 1.4×	905 1.2×	135	10.2k
Hiroaki Okuyama Japan	29	2.6k 0.6×	1.8k 0.5×	1.8k 0.7×	552 0.4×	575 0.7×	57	5.0k
Laura D. Wood United States	46	3.1k 0.8×	5.2k 1.4×	2.9k 1.1×	1.6k 1.3×	513 0.7×	155	8.6k
Adalberto Benito‐Hernández Spain	8	4.4k 1.1×	6.1k 1.6×	2.6k 0.9×	703 0.6×	660 0.9×	21	8.3k
M. OʼReilly United States	14	3.7k 0.9×	1.9k 0.5×	2.2k 0.8×	741 0.6×	719 0.9×	30	6.0k
Erinn B. Rankin United States	37	3.4k 0.8×	1.5k 0.4×	3.1k 1.1×	1.0k 0.8×	1.1k 1.4×	71	7.0k
Ferry A.L.M. Eskens Netherlands	43	2.6k 0.6×	2.9k 0.8×	1.2k 0.4×	1.5k 1.2×	461 0.6×	161	6.4k

Countries citing papers authored by Shan Man

Since Specialization

Citations

This map shows the geographic impact of Shan Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Man more than expected).

Fields of papers citing papers by Shan Man

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Man. The network helps show where Shan Man may publish in the future.

Co-authorship network of co-authors of Shan Man

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Man. A scholar is included among the top collaborators of Shan Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Man. Shan Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Man, Shan, et al.. (2023). Cross-border Urban Networks Based on Manufacturing Global Value Chain: A Study of Listed Companies in Western China. Chinese Geographical Science. 33(6). 1033–1052. 1 indexed citations

Khan, Kabir A., Madeleine Benguigui, Ping Xu, et al.. (2020). Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer. npj Breast Cancer. 6(1). 29–29. 28 indexed citations

Kuczynski, Elizabeth A., Janna Krueger, Annabelle Chow, et al.. (2018). Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine Tumors. Molecular Cancer Therapeutics. 17(4). 869–882. 20 indexed citations

Man, Shan, et al.. (2018). Preclinical impact of high dose intermittent antiangiogenic tyrosine kinase inhibitor pazopanib in intrinsically resistant tumor models. Angiogenesis. 21(4). 793–804. 4 indexed citations

Shaked, Yuval, Elizabeth Pham, Santosh Hariharan, et al.. (2016). Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy. Cancer Research. 76(20). 5983–5993. 43 indexed citations

Pham, Elizabeth, Melissa Yin, Christian Peters, et al.. (2016). Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer. Cancer Research. 76(15). 4493–4503. 55 indexed citations

Wu, Florence T.H., Shan Man, Ping Xu, et al.. (2016). Efficacy of Cotargeting Angiopoietin-2 and the VEGF Pathway in the Adjuvant Postsurgical Setting for Early Breast, Colorectal, and Renal Cancers. Cancer Research. 76(23). 6988–7000. 45 indexed citations

Pàez‐Ribes, Marta, Shan Man, Ping Xu, & Robert S. Kerbel. (2015). Potential Proinvasive or Metastatic Effects of Preclinical Antiangiogenic Therapy Are Prevented by Concurrent Chemotherapy. Clinical Cancer Research. 21(24). 5488–5498. 17 indexed citations

Kuczynski, Elizabeth A., Christina R. Lee, Shan Man, Eric X. Chen, & Robert S. Kerbel. (2015). Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma. Cancer Research. 75(12). 2510–2519. 72 indexed citations

10.

Pham, Elizabeth, Michael J. Birrer, Scott Eliasof, et al.. (2014). Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer. Clinical Cancer Research. 21(4). 808–818. 77 indexed citations

11.

Cruz‐Muñoz, William, María Jaramillo, Shan Man, et al.. (2012). Roles for Endothelin Receptor B and BCL2A1 in Spontaneous CNS Metastasis of Melanoma. Cancer Research. 72(19). 4909–4919. 49 indexed citations

12.

Francia, Giulio, Yuval Shaked, Kae Hashimoto, et al.. (2011). Low-Dose Metronomic Oral Dosing of a Prodrug of Gemcitabine (LY2334737) Causes Antitumor Effects in the Absence of Inhibition of Systemic Vasculogenesis. Molecular Cancer Therapeutics. 11(3). 680–689. 33 indexed citations

13.

Francia, Giulio, Shan Man, Christina R. Lee, et al.. (2009). Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts. Clinical Cancer Research. 15(20). 6358–6366. 33 indexed citations

14.

Shaked, Yuval, Terence Tang, Jill Woloszynek, et al.. (2009). Contribution of Granulocyte Colony-Stimulating Factor to the Acute Mobilization of Endothelial Precursor Cells by Vascular Disrupting Agents. Cancer Research. 69(19). 7524–7528. 64 indexed citations

15.

Folkins, Chris, Yuval Shaked, Shan Man, et al.. (2009). Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1. Cancer Research. 69(18). 7243–7251. 292 indexed citations

16.

Francia, Giulio, Urban Emmenegger, Christina R. Lee, et al.. (2008). Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using β-human choriogonadotropin secreting tumor cell lines. Molecular Cancer Therapeutics. 7(10). 3452–3459. 21 indexed citations

17.

Franco, Marcela, Shan Man, Urban Emmenegger, et al.. (2006). Targeted Anti–Vascular Endothelial Growth Factor Receptor-2 Therapy Leads to Short-term and Long-term Impairment of Vascular Function and Increase in Tumor Hypoxia. Cancer Research. 66(7). 3639–3648. 126 indexed citations

18.

Shaked, Yuval, Urban Emmenegger, Giulio Francia, et al.. (2005). Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide Is an Effective Long-term Chemotherapy Treatment Strategy. Cancer Research. 65(16). 7045–7051. 100 indexed citations

19.

Ng, Sylvia S. W., Alex Sparreboom, Yuval Shaked, et al.. (2005). Metronomic ABI-007 therapy: antiangiogenic and antitumor activity of a nanoparticle albumin-bound paclitaxel. Cancer Research. 65. 702–702. 2 indexed citations

20.

Rak, Janusz, et al.. (1998). The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factor. Angiogenesis. 2(3). 203–217. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact